USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
TISSUE REGENERATION SYSTEMS, INC.
Address:
5400 Carillon Point
Kirkland, WA 98033-
Phone:
N/A
URL:
N/A
EIN:
161164531
DUNS:
611645313
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $324,688.00 2
SBIR Phase II $849,728.00 1

Award List:

Designed Bioactive Scaffolds for Mandibular Reconstruction

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$121,338.00
Agency:
HHS
Principal Investigator:
Rachel Schek
Abstract:
DESCRIPTION (provided by applicant): Craniomaxillafacial (CMF) reconstruction remains a significant challenge due to the complex geometry and the need to restore both esthetics and function, especially for large mandibular segmental defects resulting from tumor resection, trauma or congenital… More

Coated Scaffolds for Intra-Operative Protein Incorporation and Controlled Release

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$203,350.00
Agency:
HHS
Principal Investigator:
Leenaporn Jongpaiboonkit – 734-998-8405
Abstract:
DESCRIPTION (provided by applicant): The purpose of the proposal is to develop medical device coatings that bind and release therapeutic proteins, particularly growth factors. Specifically, we propose to systematically optimize and control growth factor binding and release using protocols that can… More

Engineered scaffolds for complex craniomaxillofacial reconstructions

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$849,728.00
Agency:
HHS
Principal Investigator:
Francesco Migneco – 734-615-1481
Abstract:
DESCRIPTION (provided by applicant): Large mandibular segmental defects resulting from tumor resection, trauma, and congenital anomalies remain one of the most difficult clinical challenges in CMF reconstruction. Autologous tissue grafts and synthetic materials are the current clinical gold standard… More